Amlodipine Besylate Tablet
Product Images NDC 68788-4082

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 68788-4082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1a59ceb2 1cf8 4871 85d6 518fbe49dfef 183 1)

An illustrated diagram showing a vertical arrow composed of multiple capsule and tablet shapes. The arrow points downward and features a black and white color scheme.*

FDA Label Image

Amlodipine Besylate (63bc4df8 5e26 45dd 8a05 78ee94553129 01)

Chemical structure of amlodipine besylate, showing the molecular arrangement of amlodipine linked to a benzenesulfonic acid (besylate) group.*

FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

A Kaplan-Meier analysis graph depicting composite clinical outcomes for Amlodipine versus Placebo over 24 months. The x-axis shows time in months, and the y-axis shows event rate. Two curves are displayed: one for Placebo with a higher event rate, and one for Amlodipine with a lower event rate. The graph includes a p-value, hazard ratio, and confidence interval box, and the number of subjects at risk is indicated below the time axis throughout the study period.*

FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

A forest plot showing hazard ratios with 95% confidence intervals comparing outcomes favoring Amlodipine versus placebo. Categories include overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease status, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis ranges from 0 to 2.0 hazard ratio, with data points and confidence intervals plotted for each subgroup.*

FDA Label Image

Amlodipine Besylate Tablets Usp 2.5mg (63bc4df8 5e26 45dd 8a05 78ee94553129 04)

Label for Amlodipine Besylate Tablets USP 2.5 mg, generic for Norvasc, manufactured by Lupin Limited. The label includes dosing instructions in English and Spanish, storage warnings, and various barcode elements. Tablet is described as round, pink, and imprinted U/1. The label also features the Preferred Pharmaceuticals, Inc. logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.